# Evaluation of the Effect of Neuroprotective Drug on Treatment Result in Patients After Traumatic Brain Injury

> **NCT05807503** · — · COMPLETED · sponsor: **Pomeranian Medical University Szczecin** · enrollment: 56 (actual)

## Conditions studied

- TBI (Traumatic Brain Injury)

## Interventions

- **DRUG:** Cerebrolysin

## Key facts

- **NCT ID:** NCT05807503
- **Lead sponsor:** Pomeranian Medical University Szczecin
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-01
- **Primary completion:** 2022-10-31
- **Final completion:** 2022-11-30
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2023-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05807503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05807503, "Evaluation of the Effect of Neuroprotective Drug on Treatment Result in Patients After Traumatic Brain Injury". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05807503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*